Facebook Pixel

New "HAS-BLED" Tool Assesses Risk for those with Atrial Fibrillation

Rate This

One of the most common questions we get centers around the use of anticoagulant drugs, either the brand drug, Coumadin, or the generic version, warfarin and whether or not an atrial fibrillation patient should be on them. Anticoagulants decrease stroke risk, but can also increase bleeding risk. How do you sort it all out? It's just as frustrating for our doctors as it is for us.

A new tool, called HAS-BLED, may help. Used in conjunction with CHADS2 scores, it can help doctors assess our risks and determine whether or not we should be on anticoagulants.

Read more about this new tool at: New "HAS-BLED" Tool Identifies Those with Atrial Fibrillation at Risk for Bleeding From Coumadin or Warfarin

Mellanie True Hills Bio

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Atrial Fibrillation

Get Email Updates

Atrial Fibrillation Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!